Re: 'Association between IgG antibody levels and adverse events after first and second BNT162b2 mRNA vaccine doses' by Braun et al.

Zhou, Yuchi; Liu, Xiangting; Wang, Xia; Li, Hui; Zeng, Guangting

Re: 'Association between IgG antibody levels and adverse events after first and second BNT162b2 mRNA vaccine doses' by Braun et al.

Zhou, Yuchi; Liu, Xiangting; Wang, Xia; Li, Hui; Zeng, Guangting.

Zhou Y; Urology Department, The Fourth People's Hospital of Chenzhou, Chenzhou, China.
Liu X; Reproductive Medicine Center, The First People's Hospital of Chenzhou, Xiangnan University, Chenzhou, China.
Wang X; Department of Pharmacy, The First People's Hospital of Chenzhou, Xiangnan University, Chenzhou, China.
Li H; Department of Pharmacy, The First People's Hospital of Chenzhou, Xiangnan University, Chenzhou, China.
Zeng G; Department of Pharmacy, The First People's Hospital of Chenzhou, Xiangnan University, Chenzhou, China. Electronic address: 1090651185@qq.com.

Clin Microbiol Infect ; 28(12): 1671-1672, 2022 Dec.

Article in English | MEDLINE | ID: covidwho-1990980

Subject(s)

BNT162 Vaccine; Immunoglobulin G; Humans; Vaccines, Synthetic; Antibodies, Viral

Keywords

Adverse events; BNT162b2 mRNA vaccine; IgG antibody; Long COVID; PostCOVID-19 syndrome

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunoglobulin G / BNT162 Vaccine Topics: Vaccines Limits: Humans Language: English Journal: Clin Microbiol Infect Journal subject: Communicable Diseases / Microbiology Year: 2022 Document Type: Article Affiliation country: J.cmi.2022.07.028

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google